BioSpace News Archive

The U.S. Food and Drug Administration continued to take action in the ongoing response to the COVID-19 pandemic

ESSA Pharma Inc. (“ESSA”, or the “Company”) (NASDAQ: EPIX) (TSX-V: EPI), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today provided a corporate update and reported financial results for the fiscal third quarter ended June 30, 2020.

Horizon Therapeutics plc announced the pricing of its underwritten public offering of 11,800,000 of its ordinary shares at a price to the public of $71.00 per share.

Protalix BioTherapeutics, Inc. (NYSE American: PLX) (TASE: PLX), a biopharmaceutical company focused on the development, production and commercialization of recombinant therapeutic proteins produced by its proprietary ProCellEx® plant cell-based protein expression system

Mycovia Pharmaceuticals, Inc. (“Mycovia”) today announced Chief Executive Officer, Patrick Jordan, was named Life Sciences CEO of the Year by the Triangle Business Journal (TBJ).

Renowned professor and orthopedic surgeon known for her extensive research and care of children with cerebral palsy, scoliosis and clubfoot joins the Children’s Colorado team

Scientia Vascular, a leading innovator in the field of stroke treatment technology, recently received FDA clearance for its Zoom WireTM line of interventional guidewires, which are used to gain access during ischemic and hemorrhagic stroke and other challenging neurovascular and peripheral vascular procedures.

Gilead Sciences (Gilead) has recently come under fire for allegedly withholding a safer, more efficient drug than the highly toxic tenofovir disoproxil fumarate (TDF).

JanOne Inc. (Nasdaq: JAN), a company focused on bringing treatments to market for conditions that cause severe pain and drugs with non-addictive, pain-relieving properties, has entered into an agreement with CATO SMS, a world-leading, international regulatory and clinical contract research organization (CRO).

Appoints Ben Cravatt, Ph.D., Professor and the Norton B. Gilula Chair of Chemical Biology in the Department of Chemistry at The Scripps Research Institute